This submission builds on Applied BioCode’s prior FDA clearance of the BioCode® Gastrointestinal Pathogen Panel (GPP) with the KingFisher™ Flex system, demonstrating the company’s continued success in ...
CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...
Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 Flu Plus Assay. This PCR-based, ...
This webinar will explore how microfluidic singleplex qPCR enables simultaneous detection of multiple respiratory pathogens across diverse sample types in surveillance settings. We'll begin with an ...
Scientists and policymakers have devised many strategies to reduce the emergence and spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing ...
New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow Integrated DNA Technologies is revealing a new next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback